| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1011671126 |
| P356 | DOI | 10.1007/S00213-015-4003-1 |
| P932 | PMC publication ID | 4561584 |
| P698 | PubMed publication ID | 26141193 |
| P5875 | ResearchGate publication ID | 279754029 |
| P50 | author | Leslie Renee Amodeo | Q83688600 |
| Cynthia Crawford | Q67299214 | ||
| P2093 | author name string | Li Wang | |
| Christopher P Plant | |||
| Joseph A Pipkin | |||
| Shannon E Eaton | |||
| Venuz Y Greenfield | |||
| Danielle E Humphrey | |||
| Zachary R Harmony | |||
| Veronica Varela | |||
| Jelesa D Johnson | |||
| P2860 | cites work | The influence of buspirone, and its metabolite 1-PP, on the activity of paroxetine in the mouse light/dark paradigm and four plates test | Q73289665 |
| [The delayed sensitization of CRH response developed after chronic variable stress on the acoustic startle reflex] | Q83629099 | ||
| Paroxetine treatment in children and adolescents with major depressive disorder: a randomized, multicenter, double-blind, placebo-controlled trial | Q83834246 | ||
| Comparison of venlafaxine extended release versus paroxetine for treatment of patients with generalized anxiety disorder | Q83867056 | ||
| Antidepressants and Body Weight | Q22305456 | ||
| Newer generation antidepressants for depressive disorders in children and adolescents | Q24202873 | ||
| The epidemiology of depression and the evolution of treatment | Q26859199 | ||
| Antidepressant use in persons aged 12 and over: United States, 2005-2008 | Q28267258 | ||
| The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R) | Q29547223 | ||
| Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis | Q29619093 | ||
| Phasic and sustained fear are pharmacologically dissociable in rats | Q30466236 | ||
| Acute anxiogenic-like effects of selective serotonin reuptake inhibitors are attenuated by the benzodiazepine diazepam in BALB/c mice | Q30467213 | ||
| Effects of periadolescent fluoxetine and paroxetine on elevated plus-maze, acoustic startle, and swimming immobility in rats while on and off-drug | Q30473392 | ||
| Fluoxetine exerts age-dependent effects on behavior and amygdala neuroplasticity in the rat. | Q30477109 | ||
| Paradoxical anxiogenic response of juvenile mice to fluoxetine | Q30491364 | ||
| Acute administration of leptin produces anxiolytic-like effects: a comparison with fluoxetine | Q33756416 | ||
| Short- and long-term functional consequences of fluoxetine exposure during adolescence in male rats. | Q33843546 | ||
| Fluoxetine versus sertraline and paroxetine in major depressive disorder: changes in weight with long-term treatment | Q33927235 | ||
| Comparative benefits and harms of second-generation antidepressants for treating major depressive disorder: an updated meta-analysis | Q34029684 | ||
| Gender differences in depression. Critical review | Q34096002 | ||
| Chronic fluoxetine treatment in middle-aged rats induces changes in the expression of plasticity-related molecules and in neurogenesis. | Q34119432 | ||
| Effect of chronic fluoxetine treatment on male and female rat erythrocyte and prefrontal cortex fatty acid composition | Q34126331 | ||
| Antidepressants and the risk of suicide, attempted suicide, and overall mortality in a nationwide cohort | Q34587359 | ||
| Update in the methodology of the chronic stress paradigm: internal control matters | Q35035309 | ||
| Drug therapy for patients with eating disorders | Q35137925 | ||
| Pharmacological modulation of stress-induced behavioral changes in the light/dark exploration test in male C57BL/6J mice | Q35374971 | ||
| ACNP Task Force report on SSRIs and suicidal behavior in youth | Q36327813 | ||
| Effects of adolescent fluoxetine treatment on fear-, anxiety- or stress-related behaviors in C57BL/6J or BALB/cJ mice | Q36952517 | ||
| Anxiety disorders and suicidal behaviour: an update | Q37087226 | ||
| Lower anxiogenic effects of serotonin agonists are associated with lower activation of amygdala and lateral orbital cortex in adolescent male rats | Q37266988 | ||
| Treatment of major depression in adolescents: weighing the evidence of risk and benefit in light of black box warnings | Q37505303 | ||
| Pharmacotherapy of major depressive disorder in adolescents. | Q37681565 | ||
| The impact of depression in heart disease | Q37738382 | ||
| Impact of the 2004 Food and Drug Administration pediatric suicidality warning on antidepressant and psychotherapy treatment for new-onset depression. | Q37790597 | ||
| Gender differences in depression | Q37806752 | ||
| Prevalence and clinical course of depression: a review. | Q37912685 | ||
| Anxiety disorders and risk for suicide: why such controversy? | Q37955147 | ||
| A meta-analysis of cognitive functions in children and adolescents with major depressive disorder | Q38215541 | ||
| Differential diagnosis of bipolar disorder and major depressive disorder | Q38297850 | ||
| Understanding the role of adjunctive nonpharmacological therapies in management of the multiple pathways to depression | Q38300376 | ||
| Multiparous species present problems (and possibilities) to developmentalists | Q41382583 | ||
| Interactions of fluoxetine with metabolism of dopamine and serotonin in rat brain regions | Q41985332 | ||
| Adolescent fluoxetine treatment decreases the effects of neonatal immune activation on anxiety-like behavior in mice. | Q42599008 | ||
| Experimental anxiety and antidepressant drugs: the effects of moclobemide, a selective reversible MAO-A inhibitor, fluoxetine and imipramine in mice | Q42641727 | ||
| The safety and tolerability of duloxetine compared with paroxetine and placebo: a pooled analysis of 4 clinical trials | Q43051350 | ||
| Effects of swim stress and fluoxetine on 5-HT1A receptor gene expression and monoamine metabolism in the rat brain regions | Q43414486 | ||
| Methylenendioxyamphetamine produces serotonin nerve terminal loss and diminished behavioural and neurochemical responses to the antidepressant fluoxetine | Q44553347 | ||
| Chronic fluoxetine treatment partly attenuates the long-term anxiety and depressive symptoms induced by MDMA ('Ecstasy') in rats | Q44662300 | ||
| Prenatal cocaine exposure potentiates paroxetine-induced desensitization of 5-HT2A receptor function in adult male rat offspring. | Q44842577 | ||
| Baseline startle amplitude and prepulse inhibition in Vietnam veterans with posttraumatic stress disorder | Q45335461 | ||
| Reduced efficacy of fluoxetine following MDMA ("Ecstasy")-induced serotonin loss in rats | Q46341068 | ||
| Profiling of behavioral changes and hippocampal gene expression in mice chronically treated with the SSRI paroxetine | Q46482293 | ||
| Effects of chronic treatment with fluvoxamine and paroxetine during adolescence on serotonin-related behavior in adult male rats | Q46656218 | ||
| Findings from the Treatment for Adolescents with Depression Study (TADS): what have we learned? What do we need to know? | Q46970440 | ||
| Involvement of 5-HT2C and 5-HT1A receptors of the basolateral nucleus of the amygdala in the anxiolytic effect of chronic antidepressant treatment. | Q47826786 | ||
| Short-term fluoxetine treatment alters monoamine levels and turnover in discrete brain nuclei | Q48090698 | ||
| MDMA (ecstasy) inhibition of MAO type A and type B: comparisons with fenfluramine and fluoxetine (Prozac). | Q48099202 | ||
| Suppressive effect of paroxetine, a selective serotonin uptake inhibitor, on tetrahydrobiopterin levels and dopamine as well as serotonin turnover in the mesoprefrontal system of mice | Q48141961 | ||
| Anatomic and physiologic substrates of emotion in an animal model | Q48348216 | ||
| Effects of acute fluoxetine, paroxetine and desipramine on rats tested on the elevated plus-maze | Q48374832 | ||
| Time course of brain serotonin metabolism after cessation of long-term fluoxetine treatment in the rat | Q48391444 | ||
| Sertraline behavioral response associates closer and dose-dependently with cortical rather than hippocampal serotonergic activity in the rat forced swim stress | Q48448490 | ||
| Early intervention with fluoxetine reverses abnormalities in the serotonergic system and behavior of rats exposed prenatally to dexamethasone | Q48468880 | ||
| A study of the role of serotonin in the anxiolytic effect of nitrous oxide in rodents | Q48476140 | ||
| Effects of short- and long-term administration of fluoxetine on the monoamine content of rat brain | Q48500625 | ||
| MPTP-induced hippocampal effects on serotonin, dopamine, neurotrophins, adult neurogenesis and depression-like behavior are partially influenced by fluoxetine in adult mice | Q48558309 | ||
| Activation of amygdala cholecystokininB receptors potentiates the acoustic startle response in the rat. | Q48794724 | ||
| Differential behavioural and neurochemical outcomes from chronic paroxetine treatment in adolescent and adult rats: a model of adverse antidepressant effects in human adolescents? | Q48909201 | ||
| Startle response and anxiety sensitivity: subcortical indices of physiologic arousal and fear responding. | Q50569919 | ||
| The effects of sertraline and fluoxetine on anxiety in the elevated plus-maze test in mice. | Q51074546 | ||
| Acute and chronic effects of gepirone and fluoxetine in rats tested in the elevated plus-maze: an ethological analysis. | Q51082851 | ||
| Principles and pitfalls in the analysis of prenatal treatment effects in multiparous species. | Q52231565 | ||
| Fluoxetine Versus Sertraline and Paroxetine in Major Depressive Disorder | Q56138336 | ||
| P433 | issue | 19 | |
| P921 | main subject | fluoxetine | Q422244 |
| teenager | Q1492760 | ||
| P304 | page(s) | 3515-3528 | |
| P577 | publication date | 2015-07-05 | |
| P1433 | published in | Psychopharmacology | Q1422802 |
| P1476 | title | Effects of acute or repeated paroxetine and fluoxetine treatment on affective behavior in male and female adolescent rats | |
| P478 | volume | 232 |
| Q104737888 | A novel arousal-based individual screening reveals susceptibility and resilience to PTSD-like phenotypes in mice |
| Q91936544 | Adolescent fluoxetine history impairs spatial memory in adult male, but not female, C57BL/6 mice |
| Q58599135 | Fluoxetine exposure in adolescent and adult female mice decreases cocaine and sucrose preference later in life |
| Q38857229 | Newborn Brain Function Is Affected by Fetal Exposure to Maternal Serotonin Reuptake Inhibitors. |
| Q89866090 | Oleuropein Reverses Repeated Corticosterone-Induced Depressive-Like Behavior in mice: Evidence of Modulating Effect on Biogenic Amines |
| Q48067919 | Sex differences in the ontogeny of CRF receptors during adolescent development in the dorsal raphe nucleus and ventral tegmental area |
| Q30378909 | Sex differences, learning flexibility, and striatal dopamine D1 and D2 following adolescent drug exposure in rats |
Search more.